Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-22-047426
Filing Date
2022-08-24
Accepted
2022-08-24 21:00:56
Documents
1
Period of Report
2022-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 3509
  Complete submission text file 0001209191-22-047426.txt   4811
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Issuer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799
Business Address
Tross Stuart A (Reporting) CIK: 0001589641 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-50865 | Film No.: 221192769